跳至主要内容
临床试验/NCT00987857
NCT00987857Unknown不适用

Barrett's Oesophagus Two Yearly Surveillance Versus Endoscopy at Need: a Randomised Controlled Trial to Estimate Effectiveness and Cost-effectiveness Study (BOSS)

Gloucestershire Hospitals NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 3,400 人开始时间: 2009年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
3,400
试验地点
2
主要终点
Overall survival

研究概览

简要总结

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment. It is not yet known whether endoscopy every 2 years is more effective than endoscopy only as needed in finding esophageal cancer in patients with Barrett esophagus.

PURPOSE: This randomized phase III trial is studying endoscopy every 2 years to see how well it works compared with endoscopy only as needed in monitoring patients with Barrett esophagus.

详细描述

OBJECTIVES:

Primary

  • To establish whether endoscopic surveillance every 2 years or endoscopy at need only is superior in terms of overall survival and, if neither is superior, whether endoscopy at need only is non-inferior to surveillance every 2 years in patients with Barrett esophagus.

Secondary

  • To estimate the cost-effectiveness of endoscopic surveillance every 2 years as compared to endoscopy at need only.
  • To establish whether there is a significant difference between endoscopic surveillance every 2 years or endoscopy at need only in terms of the incidence of esophageal cancer, gastric or esophageal cancer, or all cancers.
  • To establish whether there is a significant difference between endoscopic surveillance every 2 years or endoscopy at need only in terms of the time to diagnosis of esophageal adenocarcinoma.
  • To establish whether there is a significant difference between endoscopic surveillance every 2 years or endoscopy at need only in terms of the stage of esophageal adenocarcinoma at diagnosis using TNM staging.
  • To establish whether there is a significant difference between endoscopic surveillance every 2 years or endoscopy at need only in terms of morbidity and mortality related to endoscopy, esophageal surgery, and other endoscopy-related interventions (e.g., ablation).
  • To establish whether there is a significant difference between endoscopic surveillance every 2 years or endoscopy at need only in terms of the frequency of endoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: comparison of screening methods (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: endoscopic biopsy (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: diagnostic endoscopic procedure (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: 2 yearly endoscopy (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: endoscopic procedure (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: quality-of-life assessment (Procedure)

2 yearly endoscopies

Active Comparator

Two years endoscopies

干预措施: screening method (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: 2 yearly endoscopy (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: comparison of screening methods (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: diagnostic endoscopic procedure (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: endoscopic biopsy (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: endoscopic procedure (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: quality-of-life assessment (Procedure)

endoscopy at need

Experimental

Endoscopy only when patient reports symptoms

干预措施: screening method (Procedure)

结局指标

主要结局

Overall survival

次要结局

  • Time to diagnosis of esophageal adenocarcinoma
  • Frequency of endoscopy
  • Morbidity and mortality related to endoscopy, esophageal surgery, and other endoscopy-related interventions
  • Stage of esophageal adenocarcinoma at diagnosis using TNM staging
  • Cost-effectiveness
  • Incidence of esophageal cancer, gastric or esophageal cancer, or all cancers

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Clive Stokes

Professor Hugh Barr

Gloucestershire Hospitals NHS Foundation Trust

研究点 (2)

Loading locations...

相似试验